Neuf :
80,00 €
Prix conseillé: 265,94 €

Le prix conseillé est le prix de vente conseillé par le fabricant ou l'importateur du produit et fourni par le fabricant, un fournisseur ou un vendeur tiers. Amazon affiche le prix conseillé en tant que prix de référence à des fins de comparaison lorsque le prix de vente du produit appliqué sur Amazon.fr ou par au moins un distributeur était supérieur ou égal à ce prix conseillé au cours des 90 derniers jours.
Plus d'informations
Économisez : 185,94 € (70 %)
Tous les prix incluent la TVA.
Livraison à 5€ 30 novembre - 6 décembre. Détails
Il ne reste plus que 1 exemplaire(s) en stock.
80,00 € € () Options sélectionnées incluses. Comprend le paiement mensuel initial et les options sélectionnées. Détails
Prix
Sous-total
80,00 € €
Sous-total
Ventilation du paiement initial
Les frais d’expédition, la date de livraison et le total de la commande (taxes comprises) indiqués lors de la finalisation de la commande.
Image du logo de l'application Kindle

Téléchargez l'application Kindle gratuite et commencez à lire des livres Kindle instantanément sur votre smartphone, tablette ou ordinateur - aucun appareil Kindle n'est requis.

Lisez instantanément sur votre navigateur avec Kindle pour le Web.

Utilisation de l'appareil photo de votre téléphone portable - scannez le code ci-dessous et téléchargez l'application Kindle.

Code QR pour télécharger l'application Kindle

Pharmacology of G Protein Coupled Receptors Relié – 12 novembre 2011


Prix Amazon
Neuf à partir de Occasion à partir de
Format Kindle
Relié
80,00 €
80,00 €
{"desktop_buybox_group_1":[{"displayPrice":"80,00 €","priceAmount":80.00,"currencySymbol":"€","integerValue":"80","decimalSeparator":",","fractionalValue":"00","symbolPosition":"right","hasSpace":true,"showFractionalPartIfEmpty":true,"offerListingId":"hNocV8L2wQgMx8qZvWxI0mFci7PpZoP6vUNiW6Ixnn32ndMCRQTR4OuHVb%2FQABirLdPBf6kBY%2B7LiVXq68tbixY%2BpP5mJO%2BRWH0f0gtIRLA%2FRi3t4XE5b2hSanhBRCNKMNNiValA2MJUFiXX1hIJGQTSCyidqEf%2FGYtBUUa50X3UCGyh0WYKiw%3D%3D","locale":"fr-FR","buyingOptionType":"NEW","aapiBuyingOptionIndex":0}]}

Options d'achat et paniers Plus

Description du produit

Biographie de l'auteur

Dr. S. J. Enna received his B.A. degree (1965, Biology) from Rockhurst University, Kansas City, Missouri and both his M.S. (1967, Pharmacology) and Ph.D. (1970, Pharmacology) degrees from the University of Missouri-Kansas City. Postdoctoral training in pharmacology was completed at the University of Texas Southwestern Medical School in Dallas, at F. Hoffmann La Roche in Basel, Switzerland, and the Department of Pharmacology and Experimental Therapeutics at Johns Hopkins University School of Medicine in Baltimore. Dr. Enna spent 10 years on the faculty at the University of Texas Medical School at Houston in the Departments of Pharmacology and Neurobiology. While at the University of Texas Dr. Enna was also a consultant for ICI USA, Inc., Merck, Sharp and Dohme Research Laboratories, Bristol Myers Corporation, and Panlabs, Inc. From 1986 1990, Dr. Enna was Senior Vice President and Scientific Director of Nova Pharmaceutical Corporation in Baltimore, and Executive Vice President from 1990 1992. He is currently Associate Dean for Research and Graduate Education as well as Professor of Physiology and of Pharmacology at the University of Kansas Medical School. Dr. Enna served as chair of the Department of Pharmacology, Toxicology and Therapeutics at the University of Kansas Medical School from 1992 to 2003. Other previous academic appointments include Lecturer in the Department of Neuroscience at The Johns Hopkins University School of Medicine in Baltimore and Adjunct Professor of Pharmacology at Tulane University School of Medicine in New Orleans.

Dr. Enna served for six years as editor of The Journal of Pharmacology and Experimental Therapeutics, and is currently co-editor of Current Protocols in Pharmacology. He is also Editor-in-Chief of Biochemical Pharmacology, Executive Editor-in-Chief of Pharmacology and Therapeutics and Series Editor of Advances in Pharmacology. Besides his editorships, Dr. Enna serves on the editorial boards of Brain Research, Life Sciences and CNS Drug Reviews. He has been the recipient of Research Career Development Awards from the National Institute of Mental Health and the National Institute for Neurological, Communicative Disorders and Stoke. Other awards include the John Jacob Abel Award and the Torald Sollmann Award from the American Society for Pharmacology and Experimental Therapeutics, the Daniel H. Efron Award from the American College of Neuropsychopharmacology, and a PhARMA Foundation Excellence Award. In recent years he has been a member of the Scientific Advisory Council of Abbott Laboratories, has served on the Board of Directors of the Life Sciences Research Office, and on the Scientific Advisory Board of the National Alliance for Autism Research. He is currently a member of the Basic Pharmacology Advisory Committee of the PhARMA Foundation. Dr. Enna has held many elective offices in professional societies including the presidency of the American Society for Pharmacology and Experimental Therapeutics (ASPET). Since 2006 he has served as Secretary General of the International Union of Basic and Clinical Pharmacology (IUPHAR).

Dr. Enna's research interests include neuropharmacology, neurochemistry and neuropsychiatric disorders. He has made significant contributions in defining the pharmacological and biochemical properties of neurotransmitter receptors, in particular those for GABA. He has also conducted research into the effects of hormones on neurotransmitter receptor function and receptor responses to psychotherapeutics, the development of receptor antagonists for NMDA, cholinergic muscarinic and bradykinin receptors, and the identification of the cellular components of coincident signaling in brain. Dr. Enna's research is described in over 200 published research reports, reviews, and book chapters. He has authored or edited over three dozen books on topics ranging from neuropharmacology in general, to neurotransmitter receptors and GABA.

Détails sur le produit

  • Éditeur ‏ : ‎ Academic Press Inc (12 novembre 2011)
  • Langue ‏ : ‎ Anglais
  • Relié ‏ : ‎ 408 pages
  • ISBN-10 ‏ : ‎ 0123859522
  • ISBN-13 ‏ : ‎ 978-0123859525
  • Poids de l'article ‏ : ‎ 680 g
  • Dimensions ‏ : ‎ 15.24 x 2.39 x 22.86 cm

Commentaires client

Il n'y a pour l'instant aucun commentaire client